Evidence map›Paper›PMID 40805544›Full record

ArticleMaterials (Basel, Switzerland)2025

High-Yield Precursor-Derived Si-O Ceramics: Processing and Performance.

Xia Zhang, Bo Xiao, Yongzhao Hou, Guangwu Wen

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xia ZhangSchool of Chemistry and Chemical Engineering, Shandong University of Technology, Zibo 255000, China.
Bo XiaoSchool of Chemistry and Chemical Engineering, Shandong University of Technology, Zibo 255000, China.
Yongzhao HouSchool of Materials Science and Engineering, Shandong University of Technology, Zibo 255000, China.ORCID 0000-0002-8389-1683
Guangwu WenSchool of Chemistry and Chemical Engineering, Shandong University of Technology, Zibo 255000, China.

Funding

National Natural Science Foundation of China ZR2021QE200
6 · The paper itself

Abstract

The precursor-derived ceramic route is recognized as an advanced and efficient technique for fabricating ceramic matrix composites, particularly suitable for the development and microstructural tailoring of continuous fiber-reinforced ceramic matrix composites. In this work, octamethylcyclotetrasiloxane and tetravinylcyclotetrasiloxane were employed as monomers to synthesize a branched siloxane via ring-opening polymerization. A subsequent hydrosilylation reaction led to the formation of polyvinylsiloxane with a three-dimensional crosslinked structure. The precursor exhibited excellent fluidity, adjustable viscosity, and superior thermosetting characteristics, enabling efficient impregnation and densification of reinforcements through the polymer infiltration and pyrolysis process. Upon pyrolysis, the polyvinylsiloxane gradually converted from an organic polymer to an amorphous inorganic ceramic phase, yielding silicon oxycarbide ceramics with a high ceramic yield of 81.3%. Elemental analysis indicated that the resulting ceramic mainly comprised silicon and oxygen, with a low carbon content. Furthermore, the material demonstrated a stable dielectric constant (~2.5) and low dielectric loss (<0.01), which are beneficial for enhanced thermal stability and dielectric performance. These findings offer a promising precursor system and process reference for the low-cost production of high-performance, multifunctional ceramic matrix composites with strong potential for engineering applications.

Indexed as

anionic ring openingceramic precursorceramic yieldpyrolysiswave-transparent

Identifiers

PMID40805544
PMCPMC12348214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.